Study: Myo-inositol may lower gestational diabetes risk

01/31/2013 | Reuters

Taking myo-inositol supplements may reduce the likelihood of gestational diabetes among pregnant women at risk for the condition, according to a small study in Diabetes Care. Data on 220 pregnant women with a family history of type 2 diabetes showed 6% of those who took myo-inositol supplements in addition to folic acid developed gestational diabetes, compared with 15% of those only given folic acid.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR